Ma, Y., Yamazaki, T., Yang, H., Kepp, O., Galluzzi, L., Zitvogel, L., . . . Kroemer, G. (2013). Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Landes Bioscience.
Chicago Style CitationMa, Yuting, Takahiro Yamazaki, Heng Yang, Oliver Kepp, Lorenzo Galluzzi, Laurence Zitvogel, Mark J. Smyth, and Guido Kroemer. Tumor Necrosis Factor Is Dispensable for the Success of Immunogenic Anticancer Chemotherapy. Landes Bioscience, 2013.
MLA CitationMa, Yuting, et al. Tumor Necrosis Factor Is Dispensable for the Success of Immunogenic Anticancer Chemotherapy. Landes Bioscience, 2013.
Warning: These citations may not always be 100% accurate.